Sophia Gayle

Sophia Gayle

Company: Cybrexa Therapeutics

Job title: Associate Director of Biology


Sophia Gayle trained in Tian Xu’s lab in the Yale School of Medicine establishing forward genetic transposon technologies in human embryonic stem cells. She went on to become a Senior Research Scientist at LAM Therapeutics in Guilford, CT. At LAM, Sophia worked on the repurposing of clinical-stage drugs for rare disease and cancer indications as well as on the preclinical development of one of LAM Therapeutics’ lead compounds for Non-Hodgkin lymphoma. Currently Sophia serves as Associate Director of Biology for Cybrexa Therapeutics in New Haven, CT. At Cybrexa, Sophia assists in overseeing the preclinical development of Cybrexa’s novel tumor-targeting alphalex technology and DNA Damage Response inhibitor portfolio for solid tumor indications. 


Utilizing alphalexTM to Empower New Applications and Combinations of Existing DDR Therapies 12:00 pm

Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.